The telmisartan and amlodipine combination in the treatment of hypertension
| Autor: | G G Shehyan, A A Yalymov, A M Schikota, V S Zadionchenko, S I Varentsov |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2014 |
| Předmět: | |
| Zdroj: | Системные гипертензии, Vol 11, Iss 1, Pp 64-72 (2014) |
| Druh dokumentu: | article |
| ISSN: | 2075-082X 2542-2189 |
| Popis: | The following review assesses socially significant disease - hypertension (AH) - and the problem of finding an effective antihypertensive therapy. Twynsta® drug (manufacturer Boehringer Ingelheim Pharma) - modern combined antihypertensive drug, which not only provides effective blood pressure control, but also due to the protective effect has been proved for all target organs improves the life expectancy of patients with hypertension. The clinical studies show that combination of telmisartan and amlodipine provides additional benefits in the treatment of patients with metabolic syndrome (by improving the carbohydrate and lipid metabolism), patients with impaired renal function (by inducing the regression of proteinuria), as well as left ventricular hypertrophy (by causing regression of the latter). The recently completed studies have shown that telmisartan acts as a selective PPAR-receptor modulator.In the present review it is shown that Twynsta® represents modern combined antihypertensive drugs and has a clinically proven favorable efficacy and safety profile. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|